openPR Logo
Press release

Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026

02-05-2019 08:10 PM CET | Health & Medicine

Press release from: Transparency Market Research

Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026

Cytomegalovirus (CMV) is a common virus that occurs widely among the population. In the U.S., 50%-85% of adults have been infected with cytomegalovirus (CMV). Most people who are infected with the virus do not experience any significant symptoms or health problems. CMV testing involves either a measurement of cytomegalovirus antibodies, immune proteins produced in response to CMV exposure, or the detection of the virus itself. CMV is found in many body fluids during an active infection, including saliva, urine, blood, breast milk, semen, vaginal secretions, and cerebrospinal fluid. It is easily transmitted to others through close physical contact or by contact with infected objects such as diapers or toys. The cytomegalovirus (CMV) test is important as the virus causes significant health problems among the population. In infants, a CMV infection causes serious physical and developmental problems.

Read Report Overview:

Most newborns (about 90%) who are infected appear healthy at birth but may develop hearing or vision problems, pneumonia, seizures, and/or delayed mental development a few months later. A few babies may be stillborn, while others may have symptoms at birth such as jaundice, anemia, an enlarged spleen or liver, and a small head. CMV test assays aid in the detection of cytomegalovirus. This is likely expand the research capabilities on cytomegalovirus (CMV) drugs and enable new diagnostic and treatment applications for patients. Many research institutes and laboratories are focusing on cytomegalovirus (CMV) tests for the diagnosis of cytomegalovirus through different technologies. Modulation of a unique technology and approach by physicians ensures better functional ability of this test. New developments in pharmological and CMV vaccine therapy approaches allow to image the function of immune system at the cellular and molecular level. This is positively affecting early diagnosis and treatment of diseases.

High prevalence of chronic diseases such as cancer and diabetes , rise in the incidence of congenital CMV, increase in patient awareness about CMV, rise in research and development initiatives, advent of high-throughput screening (HTS) for drug discovery and vaccination, and development in genomic technology are key factors driving the cytomegalovirus (CMV) test market. According to the Centers for Disease Control and Prevention (CDC), about 50% of adults in the U.S. are infected with CMV by the age of 40. Around 90% of babies born with CMV have no symptoms, but 10% to 15% develop hearing loss, normally during their first six months of life. The severity ranges from slight to total hearing loss. Despite the progress in infection rates, CMV testing is also increasing across the globe. An increase in the number of patients with cancer, rise in neonatal births rates, and rapidly increasing awareness about therapeutics and vaccines are projected to fuel the cytomegalovirus (CMV) test market. However, factors such as high cost of diagnosis are expected to hamper the cytomegalovirus (CMV) test market in the coming years.

Obtain the Brochure of the Report:

The global cytomegalovirus (CMV) test drugs market can be segmented based on assay type, application, end-user, and region. In terms of assay type, the market can be classified into enzyme-linked immunosorbent assay (ELISA), PCR assays, DNA assay, and others. Based on application, the market can be categorized into DNA probes, monoclonal antibodies, immunoassays, and others. DNA probes is a rapidly expanding segment owing to an increase in the incidence of cancer globally. In terms of end-user, the market can be split into diagnostic laboratories, pathology labs, life sciences and research labs, and others.

In terms of region, the market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global cytomegalovirus (CMV) test market due to an increase in funding for the development of research and health care infrastructure in the region. Rise in the incidence of diseases such as cancer and HIV and early phase diagnosis and treatment of the diseases are driving the biotechnology and research sector. This, in turn, is expected to boost the cytomegalovirus (CMV) test market in North America. Europe is a prominent region of the cytomegalovirus (CMV) test market due to favorable government policies regarding the development of health care infrastructure and diagnostic laboratories.

The market in Asia Pacific is expected to expand at a high growth rate during the forecast period due to a rise in birth rates, changing lifestyle, and increasing awareness among patients about diseases such as cancer and HIV, and rise in per capita expenditure. Additionally, the economic growth in India and China is augmenting health care infrastructure and boosting the expansion of pharmaceutical companies and biotech labs. This is expected to fuel the cytomegalovirus (CMV) test market in Asia Pacific in the near future.

Request Report TOC:

About Us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cytomegalovirus (CMV) Test Market to Develop Rapidly by 2026 here

News-ID: 1562646 • Views: 288

More Releases from Transparency Market Research

Cyclopentane Market to Reach US$ 533,319.84 Thousand by 2026
The global cyclopentane market was valued at US$ 284,460.87 Thousand in 2017 and is anticipated to expand at a CAGR of 6.6% from 2018 to 2026, according to a new report titled ‘Cyclopentane Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,’ published by Transparency Market Research (TMR). The global cyclopentane market is driven by rise in the demand for climate-friendly refrigerators from the consumer electronics industry. Europe
Electronic Adhesives Market to hit US$ 8,107.3 Mn by 2026
The vendor landscape of the global electronic adhesive market is highly competitive and packed with large number of players. Players are focusing towards the customization of the electronic adhesives as per different customer reqquiremnt, saya Transparancy Market Reseach. Some of the key players operating in the global electronic adhesive market are Henkel AG & Co. KGaA, Dow Chemical, HB Fuller, Kyocera Chemical Corp, 3M Company, Bondline Electronic Adhesives, Inc, Dymax
Automotive Refinish Coatings Market Worth US$ 13,231.44 Mn by 2026
The demand within the global automotive refinish coatings has been rising on account of advancements in automobile manufacturing. The need for manufacturing high-end vehicles, characterised by perfect finish and aesthetics, has given a thrust to market growth. Moreover, automobile manufacturers have established dedicated sections for repair, overhaul, and finetuning of automobiles. Therefore, the total volume of revenues within the global automotive refinish coatings market is slated to touch new values.
Global Analysis of Yogurt Market- Covid-19 Impact, Dynamics, Segments and Supply …
Yogurt is a diary product. Yogurt is produced by fermentation of milk by bacterial treatment. The bacteria in the presence of lactose in milk, produces lactic acid. The lactic acid produced by the bacterial treatment reacts with milk protein to impart the texture and taste of yogurts. Yogurt is generally produced from cows’ milk as it is readily available all across the world. Obtain Report Details @ Non-dairy yogurts

All 5 Releases

More Releases for CMV

Cytomegalovirus (CMV) Market: Size, Status, Opportunity Analysis and Forecasts t …
A new independent 162 page research with title 'Cytomegalovirus (CMV): Opportunity Analysis and Forecasts to 2027' guarantees you will remain better informed than your competition. The study covers geographic analysis that includes regions like North America, Europe or Asia and important players/vendors such as Atara Bio, Biotest AG, Helocyte, Merck & Co., Novartis, Shire, ViraCyte With n-number of tables and figures examining the Cytomegalovirus (CMV) Market, the research gives
Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market Opportunity Analy …
Cytomegalovirus (CMV) is a virus that belongs to herpes virus family that remain dormant in the human body. CMV infection can occur in people of all ages worldwide. CMV is a communicable disease that spreads through body fluids such as saliva, blood, urine, semen, and breast milk. Presence of CMV infection can be detected by various testing methods based on which the global cytomegalovirus infection treatment and diagnosis market can
Human Papillomavirus (HPV) and Cytomegalovirus (CMV) Therapeutics Market: Rise i …
Some of the prominent names in the global human papillomavirus (HPV) and cytomegalovirus (CMV) therapeutics market are Valeant Pharmaceuticals, Roche AG, Perrigo Company plc, Fougera Pharmaceuticals, Clinigen Group plc., and Fresenius Kabi USA. Of them, Valeant Pharmaceuticals accounts for a leading share in the HPV therapeutics market and Roche AG accounts for a dominant share in the CMV therapeutics market. Read Report Overview @ A report by Transparency Market Research forecasts
Cytomegalovirus (CMV) Diagnostics Market Forecast Research Reports Offers Key In …
Cytomegalovirus belongs to the herpesviridae family and is a double-stranded DNA virus. This virus mainly causes asymptomatic infections or sometimes causes mild flu like symptoms; and later remains latent throughout life, which may reactivate. Thus, this virus can remain as a lifelong companion for some individuals and can be a silent killer for the others. Cytomegalovirus (CMV) infection is characterized by the development of such antibodies, which develop due to
Cytomegalovirus (CMV) Infection Therapeutics Pipeline Analysis, 2017 by P&S Mark …
The rising number of the research and development activities for the pipeline drugs acts as drivers for the cytomegalovirus infection therapeutics pipeline. The prophylaxis treatment of cytomegalovirus is also increasing due to its effective and safe treatment. The U.S. Food and Drug Administration (USFDA) and European Medicines Agency (EMA) are supporting the cytomegalovirus infection therapeutics pipeline by encouraging the drug development process through different types of designations. The pipeline is
Cytomegalovirus (CMV) Infection Treatment and Diagnosis Market - Global Industry …
Cytomegalovirus (CMV) is a virus that belongs to herpesvirus family that remain dormant in the human body. CMV infection can occur in people of all ages worldwide. CMV is a communicable disease that spreads through body fluids such as saliva, blood, urine, semen, and breast milk. Presence of CMV infection can be detected by various testing methods based on which the global cytomegalovirus infection treatment and diagnosis market can be